How to improve long-term outcome after liver transplantation?

被引：53
作者：
Durand, Francois [1 ]
机构：
[1] Univ Paris Diderot, Hosp Beaujon, INSERM, Hepatol & Liver Intens Care, Clichy, France
来源：
LIVER INTERNATIONAL | 2018年 / 38卷
关键词：
de novo malignancy; immunosuppression; liver transplantation; metabolic syndrome; viral hepatitis; PRIMARY SCLEROSING CHOLANGITIS; RISK-FACTORS; NONALCOHOLIC STEATOHEPATITIS; HEPATITIS-B; RECIPIENTS; DISEASE; IMPACT; RECURRENCE; REJECTION; SURVIVAL;
D O I：
10.1111/liv.13651
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The outcome of liver transplantation has markedly improved in the last 3 decades. Although early post-transplantation outcomes have improved over time, this is not true of the long-term outcome. The majority of late deaths are not related to graft dysfunction, and with the advent of new antiviral agents, recurrence of hepatitis B and hepatitis C after transplantation may no longer represent a source of graft loss and patient's death in the long term. The complications of metabolic syndrome may represent an increasing source of morbidity and mortality after transplantation. This study discusses these modifiable factors associated with late mortality to improve the long-term results of transplantation.
引用
收藏
页码：134 / 138
页数：5
相关论文
共 38 条
[11]   Recurrence of autoimmune liver disease after liver transplantation: a systematic review [J].
Gautam, Manjushree ;
Cheruvattath, Rekha ;
Balan, Vijayan .
LIVER TRANSPLANTATION, 2006, 12 (12) :1813-1824
[12]   Recurrence of primary sclerosing cholangitis after liver transplantation [J].
Graziadei, IW .
LIVER TRANSPLANTATION, 2002, 8 (07) :575-581
[13]   Risk Factors of Lung, Head and Neck, Esophageal, and Kidney and Urinary Tract Carcinomas After Liver Transplantation: The Effect of Smoking Withdrawal [J].
Ignacio Herrero, J. ;
Pardo, Fernando ;
D'Avola, Delia ;
Alegre, Felix ;
Rotellar, Fernando ;
Inarrairaegui, Mercedes ;
Marti, Pablo ;
Sangro, Bruno ;
Quiroga, Jorge .
LIVER TRANSPLANTATION, 2011, 17 (04) :402-408
[14]   Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis [J].
Koo, Bo Kyung ;
Kim, Donghee ;
Joo, Sae Kyung ;
Kim, Jung Ho ;
Chang, Mee Soo ;
Kim, Byeong Gwan ;
Lee, Kook Lae ;
Kim, Won .
JOURNAL OF HEPATOLOGY, 2017, 66 (01) :123-131
[15]   Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events [J].
Laryea, Marie ;
Watt, Kymberly D. ;
Molinari, Michele ;
Walsh, Mark J. ;
McAlister, Vivian C. ;
Marotta, Paul J. ;
Nashan, Bjorn ;
Peltekian, Kevork M. .
LIVER TRANSPLANTATION, 2007, 13 (08) :1109-1114
[16]   Antibody-mediated vascular rejection of kidney allografts: a population-based study [J].
Lefaucheur, Carmen ;
Loupy, Alexandre ;
Vernerey, Dewi ;
Duong-Van-Huyen, Jean-Paul ;
Suberbielle, Caroline ;
Anglicheau, Dany ;
Verine, Jerome ;
Beuscart, Thibaut ;
Nochy, Dominique ;
Bruneval, Patrick ;
Charron, Dominique ;
Delahousse, Michel ;
Empana, Jean-Philippe ;
Hill, Gary S. ;
Glotz, Denis ;
Legendre, Christophe ;
Jouven, Xavier .
LANCET, 2013, 381 (9863) :313-319
[17]   Hepatitis B cure: From discovery to regulatory approval [J].
Lok, Anna S. ;
Zoulim, Fabien ;
Dusheiko, Geoffrey ;
Ghany, Marc G. .
JOURNAL OF HEPATOLOGY, 2017, 67 (04) :847-861
[18]   Impact of behaviors (smoking, treatment adherence, exercise, alcohol) on allograft function and outcomes [J].
Lucey, Michael R. .
LIVER TRANSPLANTATION, 2017, 23 :S89-S91
[19]   De Novo Malignant Disease After Liver Transplantation? Risk and Surveillance Strategies [J].
McCaughan, Geoffrey W. ;
Vajdic, Claire M. .
LIVER TRANSPLANTATION, 2013, 19 :S62-S67
[20]   Pretransplant Predictors of Recovery of Renal Function After Liver Transplantation [J].
Northup, Patrick G. ;
Argo, Curtis K. ;
Bakhru, Mihir R. ;
Schmitt, Timothy M. ;
Berg, Carl L. ;
Rosner, Mitchell H. .
LIVER TRANSPLANTATION, 2010, 16 (04) :440-446
1234